Home  ›  Cardiovascular Risk Associated With Medical Use of Opioids and Cannabinoids a Systematic Review

Cardiovascular Risk Associated With Medical Use of Opioids and Cannabinoids a Systematic Review

Written By Saturday, April 16, 2022 Add Comment Edit

Review Commodity

Office of cannabis in cardiovascular disorders

Introduction

Currently, cannabis is the virtually widely produced and consumed illicit drug in the world with global numbers of users budgeted 182.5 million (3.8% of global population). Similarly, information technology is the almost widely used illicit substance amidst population aged 15–64 years in Northward America with estimated annual prevalence of 11.6% (i). A recent longitudinal report showed that 12.iv% of tobacco users reported sampling of marijuana before tobacco initiation; additionally, greater utilise among blackness youth equally compared to white and among those exposed to fierce trauma was also noted (two). It has been suggested that early cannabis apply may be linked with higher possibility of chronic use in greater amounts.

Medical use of cannabis is widespread and dates back to many centuries. In parallel with the widespread increment in the recreational use of cannabis worldwide, peculiarly among immature adults, in that location have been movements towards the decriminalization of cannabis employ in various parts of the world, and in some countries, cannabis prescription is now permitted for various conditions other than the traditional cancer pain and neuropathy. Recently, several countries accept approved the clinical utilise of cannabis for various conditions. In The United States (USA), as of July 3, 2016, a total of 25 states, the District of Columbia, and Guam allow for comprehensive public medical marijuana and cannabis programs (3).

Although the widespread recreational use of cannabis is mainly due to its well-known neurological and cognitive effects, the effects of cannabis on other organ systems remain unclear to some extent and risk perceptions associated with cannabis utilise seem to be widely underestimated. In fact, a recent survey among a big adolescent population group in the US showed that about iii/4ths of adolescents thought that cannabis use was not associated with any pregnant impairment (iv). While the risk perception among youth is failing or remaining stable across the various states of the United states of america, the employ of cannabis is increasing highlighting the demand for public health policy changes regarding sensation of the risk to curb cannabis employ among youth.

Several systematic reviews, meta-analyses, randomized control trials and case–control studies have shown that the non-medicinal utilise of cannabis tin significantly affect physical and mental health and lead to substance dependence (5) and alter the psychosocial development and mental health of adolescents (6). The mutual adverse furnishings of cannabis utilise as well dependence include the risk of motor vehicle accidents, respiratory dysfunction and cardiovascular events and pathology. Cannabis apply or smoking has been linked with pneumomediastinum, pneumothorax, pneumopericardium, bullous lung disease, increased run a risk of chronic obstructive pulmonary affliction, desquamated interstitial disease, and advent of chocolate-brown pigmented macrophages (7). Jouanjus et al. (8) nerveless information from French Addictovigilance Network (2006–2010) and plant that 1.8% of all cannabis related reports (35/1079) were cardiovascular complications, mostly men (86%) of an boilerplate historic period of 34.three years. At that place were 22 cardiac complications (xx acute coronary syndromes), ten peripheral vascular and three cerebrovascular with death rate of 26% in these patients.

Thus, information technology is reasonable to conclude that the growing popularity of marijuana consumption for both medical and recreational purposes is associated with a parallel increase in the incidence of complications related to its use. Therefore, there is a need for a deep understanding of the effects of marijuana on the homo body. We provide a review of the endocannabinoid system (ECS) followed past examining the effects of cannabis on the cardiovascular organization, including the occurrence of arrhythmias and myocardial infarction (MI) and its effects on the peripheral vasculature and the cerebrovascular organisation. Nosotros conducted literature search from January 1964 to October 2016 from PubMed. Nosotros also briefly examine some of the important considerations related to anaesthesia in cannabis users.

Endocannabinoid receptors in cardiovascular arrangement

The discovery of Δ9-tetrahydrocannabinol (THC) as the master agile ingredient of Cannabis sativa (9) led to the subsequent discovery of specific receptors for THC in the human being torso, namely cannabinoid receptors type 1 (CB-one) and type 2 (CB-2). CB-1 receptors are expressed in the liver, musculus, fat, and encephalon, while CB-2 receptors are expressed in large numbers in the spleen and immune cells likewise equally in peripheral tissues, admitting at low levels (10).These findings triggered a number of studies that eventually led to the discovery of the ECS. The ECS comprises the cannabinoid receptors (CB-1 and CB-ii) as well the endogenous counterparts of THC and endogenous ligands for both cannabinoid receptors, known every bit N-arachidonoyl-ethanolamine (anandamide) and 2-arachidonoyl-glycerol (two-AG). The ECS has been establish to be involved in a number of processes, including prison cell fate and proliferation and differentiation of progenitors (11). Attributable to its wide representation of the ECS in the human torso and its interest in a variety of actual processes, this arrangement has emerged as a versatile therapeutic target. Endocannabinoids were detected in heart tissues and current evidences advise that the ECS is involved in the regulation of heart rate (Hour) and claret pressure in addition to being involved in various other pathological processes (12). Experimental studies take shown redundancy in endocannabinoid signalling and in endocannabinoid targets with dualistic function of CB-i and CB-2 receptors in the presence of pathological weather. Cumulative evidence seems to advise that CB-ane and CB-2 receptors may play contributory roles in modulating cardiometabolic risk, and atherogenesis, and can also have protective roles in limiting cardiomyocyte damage (12). ECS have been found to exert vasorelaxing effects in cardiovascular system which appears to be mediated past numerous pathways. Activation of CB1 receptors in mice have been shown to produce prolonged hypotension. THC can cause vasodilatation, independent of cannabinoid receptor activation, by activating transient receptor potential ankyrin type-1 (TRPA-1) channel. In addition, anandamide activates vanilloid VR1 receptors, (a known culling target of anandamide) present on sensory nerves triggering the release of calcitonin cistron-related peptide that binds to its receptors to cause vasodilatation (13). The CB-2 receptors are expressed in cardiomyocytes, coronary endothelial cells and shine musculus cells. Steffens and Pacher (14) examined the current literature on cannabinoid receptor CB-2 in cardiovascular disorders and ended that expression of CB-2 receptors in cellular components of the cardiovascular system equally well as infiltrating immune cells such as leukocytes and macrophages was possibly involved in controlling the extent of tissue inflammation and injury occurring in various cardiovascular atmospheric condition, thereby suggesting that these receptors may play a cardioprotective part. The pharmacological modulation of CB-2 receptors past CB-2 receptor agonists and antagonists therefore appears to exist a promising strategy in the treatment of diseases such every bit stroke, atherosclerosis, restenosis, MI and eye failure. A thorough understanding of the endocannabinoid receptor system in humans would be paramount to the discovery of molecules that exert the therapeutic effects of cannabis and cannabinoids, with minimal agin effects.

Arrhythmogenic properties of cannabis

I of the well-nigh consistent effects of cannabis smoking on heart is 20% to 100% increment in Hour which can final upwardly to 2–3 hours, often accompanied by a slight increase in supine blood pressure. This effect of cannabis on 60 minutes is thought to be due to cannabis induced vasodilation causing reflex tachycardia (15,16). Consumption of higher doses of cannabis can crusade postural hypotension associated with dizziness or fainting (17,eighteen). However, tolerance to the effects of cannabis develops speedily afterward just a day or two of repeated exposure. Chronic marijuana employ is associated with a decrease in HR, disappearance of orthostatic hypotension, increase in blood volume, and decrease in the circulatory responses to exercise which are consistent with reduced sympathetic and increased parasympathetic activity (eighteen).

A study from Norway, on apprehended drivers, demonstrated that THC- positive drivers had higher mean pulse rate than THC-negative drivers and surprisingly, the magnitude of tachycardia was independent of claret THC concentration (nineteen). Cannabis utilize has too been shown to be associated with development of atrial fibrillation especially in immature patients who don't have whatsoever risk factor (xvi,20). In a systematic review of six case reports, Korantzopoulos et al. (16) ended that marijuana smoking might be associated with atrial fibrillation. They hypothesize that adrenergic stimulation reduces duration of activity potential and alters the electrophysiological backdrop of myocardium to favour automaticity and micro-reentry thereby promoting evolution of atrial fibrillation in susceptible individuals. Moreover, atrial ischemia caused past detrimental effect of cannabis on coronary microcirculation could also contribute to evolution of atrial fibrillation (16). Ventricular tachycardia has been reported in a 29-twelvemonth-quondam heart transplant patient, inside the fourth dimension frame of marijuana use documented by a 24-hour Holter Monitor (21). Casier et al. (22) as well reported a case of fatal ventricular fibrillation in a chronic cannabis user following recent use of it. In another case, ventricular fibrillation occurred after consuming more than than the usual dose of marijuana in a patient with CAD on two separate occasions. The authors speculated that excessive catecholamine release could be responsible for the arrhythmia (23). Brugada-like ST segment abnormalities take also been reported after heavy consumption of cannabis (24-26). This agin effect of cannabis is thought to be due to its effect on shortening of action potential and hyper stimulation of vagal tone (24).

Thus, it appears that recent use of cannabis is associated with an increment in HR occurring in young individuals and potentially increasing the hazard of sudden decease. Since marijuana apply is mutual among young persons in diverse social settings and the possibility of the combined use of marijuana with booze or other illicit substances is high, it is of import to consider the potential additive or synergistic effects of unremarkably used such combinations. In a randomized, double blind, placebo controlled trial in salubrious volunteers, Ballard et al. (27) found that combining very-low-dose ethanol and oral THC capsules (ii.5 mg) did not show any synergistic outcome on physiological responses or cognitive function in healthy volunteers. Assessed measures included psychomotor ability, elementary reaction time and blood pressure and 60 minutes. However, in another randomized, double blind, placebo controlled trial, the combined employ of "ecstasy" or three,4-methylenedioxymethamphetamine (MDMA) and marijuana was examined by Dumont et al. (28) who showed that that both drugs had additive effects on increasing Hr in healthy volunteers. THC co-assistants also modulated the MDMA induced temperature increment by delaying and prolonging information technology.

Cannabis and astute coronary syndrome

In the past, risk of ischemia associated with marijuana utilize was considered to be low (18). Over the last few years, several example reports and case series accept been published worldwide about the occurrence of MI in otherwise good for you immature marijuana abusers nearly of which are particularly male. Hodcroft et al. (29) reported a case of marijuana-related MI triggered after sports activity in a patient who was a smoker but otherwise salubrious. In a case series, Casier et al. (22) reported that marijuana smoking was associated with severe, potentially fatal, acute coronary events with documentation of the occurrence of diffuse coronary spasm and astute anterior coronary infarction. Deharo et al. (xxx), Ghannem et al. (31), Yurtdas and Aydin (32), and Canga et al. (33) also reported cases of exercise-induced coronary syndromes in previously good for you young men with history of regular and excessive apply of marijuana as well as smoking cigarettes. Regular cannabis use was found to exist linked with acute coronary syndrome subsequently excessive physical activity and has been reported to trigger MI in patients with known coronary avenue affliction (34). Leblanc et al. (35) reported a example of recurrent ischemic stroke resulting from a post-MI left ventricular thrombus in a fellow who was a heavy marijuana and tobacco smoker. Together, these example studies indicate that cannabis use is a risk cistron for acute coronary events in young persons, particularly men, who do non accept any other take a chance factors for cardiovascular diseases too smoking. The events also appear to be triggered past highly strenuous physical activity. This is an of import consideration in youth who use marijuana in social entertainment settings since physical action such every bit dancing may be mutual in such circumstances, which can increase the risk of precipitating acute coronary events.

From the Determinants of Myocardial Infarction Onset Written report cohort, in a example-crossover study, Mittleman et al. (36) interviewed 3882 patients with astute myocardial infarction (AMI) to compare the reported of use of marijuana in the hour preceding symptoms onset to its expected frequency using self-matched command data. They found that marijuana smoking was associated with increased the risk of MI 4.viii times than baseline within 1 60 minutes of apply but this elevated hazard appears to subtract rapidly thereafter. Further, the annual risk of MI in daily users of cannabis was calculated to be 1.five% to 3% per year (36). In another study from the similar cohort, 1913 patient were prospectively followed for an average of 3.8 years between 1989 and 1996 with 52 patients reported to consume marijuana within a year. The authors determined that compared to not-use, cannabis use less than a week, was associated with hazard ratio of two.5 (95% CI, 0.9–7.3) and weekly or more than use was associated with risk ratio of 4.2 (95% CI, 1.ii–fourteen.3). Any cannabis use was associated with hazard ratio of one.9 (95% CI, 0.6–6.3) for cardiovascular mortality and four.ix (95% CI, ane.6–14.vii) for non-cardiovascular mortality subsequently historic period and sex adjustments (37). Yet, in a follow study from the same cohort, Frost et al. (38) could not demonstrate statistically significant association betwixt cannabis use and mortality after 18 years of follow up.

The mechanisms by which cannabis causes astute coronary syndrome are unknown and multiple hypothesis have been proposed (Table ane , Figure 1). In many reported cases of cannabis induced AMI coronary angiography was normal so cannabis-induced transient coronary vasospasm is 1 of the hypothesis proposed. In one case report, patient developed ST-segment elevation MI with clean coronaries after using combination of sildenafil and cannabis (39). Prolonged one-half-life of cannabis due to competitive substrate inhibition of CYP3A4 was proposed equally the possible mechanism (39,xl). Cannabis is also known to cause reversible cognitive vasoconstriction syndrome (RCVS) associated with or without focal neurological deficits where neurovascular imaging improves after discontinuation of cannabis use (discussed afterward in more particular). Another possible mechanism of AMI due to cannabis use could exist increase in carboxyhemoglobin levels immediately later its inhalation which could reduce oxygen carrying chapters of blood. Aronow et al. (41) showed that smoking cannabis has astute effects on cardiovascular function and on exercise-induced angina in patients with angina pectoris. In their study, they found that smoking one marijuana cigarette increased the product of systolic blood pressure (SBP) and HR and decreased practise angina threshold past 48% when compared to non-marijuana cigarettes which did non have an effect on double production and decreased exercise angina threshold by only 8.6%.

Table 1

Table 1 Proposed pathophysiology of cannabis-induced acute myocardial infarction (Depending on cardiac catheterization findings)

Full table

Figure one Proposed mechanisms for cannabis induced cardiovascular effects.

It has also been proposed that cannabis has pro-coagulant effects. Both CB1 and CB2 receptors have been detected on platelet cell membrane. It has been shown in vitro that cannabis increases expression of glycoprotein IIb-IIIa and P-selectin in a concentration dependent fashion which leads to platelets assemblage and Cistron VII activation (42) (Effigy 2). Cannabis is also postulated to exert hemodynamic effects which could initiate plaque rupture and promote thrombosis. Increase in 60 minutes and sympathomimetic activity due to cannabis use can increase myocardial oxygen demand and could precipitate AMI. Postural hypotension and increment in claret pressure in supine position tin can likewise exist precipitated by cannabis use which could trigger anginal episodes (22,36).

Figure 2 Molecular mechanisms of coaction betwixt cannabinoid system and platelets. (Platelets and megakaryocytes accept CB1 and CB2 receptors. Anandamide and two-AG activate platelets via these receptors. 2-AG has shown to increase release of platelets from megakaryocytes. 2-AG increases expression of glycoprotein IIb-IIIa on activated platelets. Activated platelets and megakaryocytes self-regulate metabolism of 2-AG via FAAH & MAGL pathway. FAAH, fat acid amide hydrolase, MAGL, monoacylglycerol lipase).

Thus, there is evidence to back up the notion that cannabis use is associated with an increased hazard of acute coronary events in patients with coronary artery disease besides equally in those without any significant risk factors for atherosclerosis. However, some investigators believe that there is only low and transient risk of precipitating cardiovascular events associated with cannabis use considering that the reports of death amidst users of medical marijuana attributable to the drug are rare (43).

Peripheral vascular effects of cannabis

The effects of cannabis on peripheral vasculature have not been clinically well studied all the same. Just a handful number of studies have been conducted on the relationship betwixt blood vasomotion and cannabis and they show conflicting results. O'Sullivan et al. (44) showed that THC causes fourth dimension dependent slow arterial relaxation in rats and that this issue was mediated by peroxisome proliferator-activated receptor-gamma (PPAR-γ). Further, their beast experiments revealed that in conduit arteries, such as the aorta, THC causes damage of methoxamine-induced constriction nether the influence of superoxide dismutase, production of hydrogen peroxide, and calcium channel inhibition. In the superior mesenteric artery, they noted that THC enhanced acetylcholine-induced vasorelaxation via increased hydrogen peroxide product. However, in isolated resistance vessels, THC augmented methoxamine-induced vasoconstriction and inhibited endothelium-dependent vasorelaxation (45). Afterward, the same authors reported that cannabidiol likewise exerted its time-dependent vascular effects past bounden to PPAR-γ (46). These findings suggest that THC has variable furnishings on the key and peripheral vessels, depending on the functional properties of the arteries examined. Vandrey et al. (47) conducted an intra-subject cross-over report and found that abrupt discontinuation of cannabis employ resulted in an increase in mean SBP and diastolic blood pressure (DBP) of 22.8 and 12.three mmHg respectively (47). In contrast, Bonnet et al. (48) recently showed in a mail-hoc assay that in patients treated for cannabis withdrawal syndrome, the precipitous cessation of marijuana was non associated with any significant alterations in claret force per unit area or HR. Alshaarawy and Elbaz (49) conducted a study using U.s. National Health and Nutrition Examination Survey-NHANES (2005–2012) data, and constitute that active cannabis utilize was associated with increase in SBP in their sex-age adjusted model and no association between cannabis employ and DBP was found. Cannabis smoking has too been shown to be associated with orthostatic hypotension which was more pronounced and longer lasting in hypertensive volunteers and is thought to be due to decreased vascular resistance (50).

An association between Cannabis use and arteritis has been suggested mainly as a crusade of peripheral vascular affliction in young patients <fifty years of age (51). THC might possess direct toxic issue on arterial vessels and could exert a synergistic effect with tobacco smoking (52). THC induced peripheral vasoconstriction could as well contribute to this miracle (51). Multiple case reports of cannabis associated arteritis have been published in literature, yet, the casualty has non been well established because almost of these cases had other risk factors for thromboangitis obliterans (34,53). In many instances, even so, the worsening of the vascular affliction was constitute to parallel the use of cannabis with halting of disease progression with abstinence from cannabis consumption (54). Lou et al. (55) reported a rare case of spontaneous autopsy of the renal artery in a cannabis user. They proposed chronic vasoconstriction, equally the possible underlying machinery by causing fractional or complete vacuolization and lysis of the arterial media with deposition of fibrin at the interface between the adventitia and the media, eventually resulting in arterial rupture. There are anecdotal case reports of central retinal vein apoplexy (56), limb ischemia (57), and astute thrombosis of aorta (58) associated with cannabis use.

Thus, the upshot of cannabinoids on peripheral vasculature is heterogeneous and complex. Further enquiry in this field is required to understand the long-term effects of cannabis consumption on the peripheral vasculature and blood flow.

Effects on cerebrovascular system

Currently, the show regarding the human relationship between stroke and cannabis use is not firmly established, although a temporal link has been reported in several cases of ischemic stroke with no other apparent causes (59). Rumalla et al. (60) conducted a written report in patients aged 18–54 years and found that recreational utilize of marijuana was independently associated with a 17% increase in hazard of hospitalization due to acute ischemic stroke. They likewise constitute that the incidence of acute ischemic stroke was greater amidst marijuana users than among non-users. Similarly, a prospective study by Wolff et al. (61) on the relationship betwixt ischemic stroke and cannabis utilise revealed that cannabis use was associated with multifocal angiopathy resulting in ischemic stroke in young individuals. Cannabis-related stroke tin can also occur as a effect of arterial obstruction from a mail service-MI left ventricular thrombus, as reported past Leblanc et al. (35). Similarly, Tsivgoulis et al. (62) reported a example of transient ischemic attacks manifested equally acute, transient episodes of hemiparesis in a patient with a history of daily cannabis consumption. In a systematic review of case reports on stroke and cannabis use past Hackam (63) showed that current evidences bespeak towards a temporal relationship between ischemic stroke and cannabis employ. They besides found that about 22% of these patients had some other ischemic stroke afterward subsequent re-exposure to cannabis which again strengthens the link between stroke and cannabis use. Cannabis related ischemic stroke has been institute to accept predilection for posterior circulation (64) which could be due to multifocal intracranial stenosis in vertebrobasilar territory (61). Thanvi and Treadwell (59) listed the following every bit possible mechanisms underlying the occurrence of stroke after cannabis consumption: vasospasm, vasculitis, hypotension with secondary impairment of regulation of cerebral flow and cerebral vasoconstriction syndrome (Figure 3). Ntlholang et al. (65) reported a few cases of stroke in cannabis users wherein they were able to obtain histological evidence showing gross hyperplasia of the tunica media leading to luminal stenosis of cerebral arteries. Recently, it was shown in rats that THC exposure induces cerebral mitochondrial dysfunction in dose dependent manner and increases reactive oxygen species production in the brain which could further contributes to its toxicity (66). This apparent relationship of cannabis use and stroke notwithstanding, it should likewise be noted that stroke is non commonly reported in cannabis users (59).

Effigy 3 Proposed mechanisms of cannabis induced cerebrovascular effects.

While several reports have indicated the occurrence of ischemic stroke associated with cannabis use but occurrence of hemorrhagic stroke has been rarely reported. Ince et al. (67) reported a case of both hemorrhagic and ischemic strokes subsequent to marijuana consumption in high doses. In a report from Nationwide Inpatient Sample (NIS) database (2004–2011), cannabis use was found to be independently associated with 18% increased likelihood of development of aneurysmal subarachnoid hemorrhage (aSAH) (68). Behrouz et al. (69) performed a retrospective study on 108 patients with aSAH out of which 25.9% were found to exist positive for cannabis on urine drug screen. They institute that most half of the cannabis positive patients developed delayed cerebral ischemia vs. only 23.8% in cannabis negative group (P=0.01). However, in another observational study in patients with spontaneous intracerebral hemorrhage (ICH), prior cannabis utilize was associated with lower admission ICH score (P=0.017) and less disability at belch in terms of modified Rankin scale (lxx).

Cannabis use can also cause RCVS which is characterized by recurrent strong headaches and development of neurological focal deficit with reversible vasoconstriction on repeat intravascular imaging within three months (71). In a prospective series of 67 patients with RCVS, xx patients (32%) were constitute to cannabis users with cannabis being the well-nigh common vasoactive drug used in the cohort (72). Wolf et al. showed that ischemic stroke due to reversible vasoconstriction without thunderclap headache was precipitated past cannabis employ in some individuals (73,74).

It is possible that cannabis employ is underdiagnosed or underreported in immature adults developing ischemic and occasionally hemorrhagic stroke. Therefore, the actual magnitude of the contribution of cannabis usage to the incidence of stroke amidst youth may be significantly underestimated. This highlights the need for proper and thorough history taking in such cases focusing on the history use of recent or chronic use of marijuana, peculiarly in the absenteeism of other risk factors for stroke. A loftier degree of suspicion of illicit drug utilize, especially of cannabis, should be maintained in young patients presenting with stroke especially when no apparent cause of stroke can exist found.

Other reported adverse cardiac effects of cannabis utilise

Takotsubo cardiomyopathy

Rarely, development of stress cardiomyopathy has been temporally related to consumption of cannabis (75). Recurrent stress cardiomyopathy involving cardiac upmost and basal cardiac regions on two separate occasions in the same patient has also been reported. Because of interest of two split up cardiac regions, authors questioned the hypothesis of reginal variability of β-adrenergic receptor density and sensitivity, and proposed that this phenomenon could be mediated by ECS (76).

Myopericarditis

A example of recurrent myopericarditis was reported in a 29-year-quondam male which occurred later heavy consumption of adulterated cannabis both times. Authors could not observe whatsoever obvious causative factor other than employ of cannabis (77).

Constructed marijuana and its cardiovascular complications

Synthetic cannabinoids (SCs) are cannabis preparations that were synthesized during the process of identifying cannabinoid receptors. They were first sold nether the name "spice" which is fabricated of cannabinomimetic JWH-018 and other cannabinoids such as CP-47, 497,497-C8 (78). JWH-018 has stronger affinity for CB1 and CB2 receptors and produces extreme cannabinomimetic effects compared to marijuana. SCs are marketed under various other names including K2, skunk, joker, mojo, olfactory property, dream and black mamba etc. (78,79) and accept gained increasing popularity because they are considered "legal" alternatives to marijuana that is safe (80). The rising popularity of these products has been accompanied by a significant increment in the number of emergency admissions due to SCs. In fact, in a study from Drug Abuse Alert Network (DAWN) in U.s.a., the number of emergency department visits specifically linked to SCs increased more than 2.5 times from xi,406 visits in 2010 to 28,531 visits in 2011 (81). At that place is considerable chance of toxicity from either acute or chronic use with testify of an increase in the number of chronic or even daily users of this class of drugs and a parallel increase in cases of withdrawal complications (82).

Although widely considered harmless, several contempo reports have been published on cases of serious cardiovascular events attributed to the use of SCs. The most prevalent cardiac side effect of SC consumption is tachycardia (83). The tachycardia is associated with elevated blood pressure level in 1/three to 3/4 of the cases (83,84). Chest pain has also been reported to occur after consumption of SCs (83). Other reported cardiovascular events are peri-mesencephalic sub-arachnoid hemorrhage and middle cerebral artery apoplexy (83). Cases of ST-elevation MI, although rare, accept been reported following the employ of K2 in patients as young equally xiv years old likewise as in adults (85). On the other hand, Orsini et al. reported a instance of non-ST-segment elevation MI leading to acute congestive heart failure (CHF) and acute hypoxemic respiratory failure, subsequently consumption of SCs (78). They hypothesized that consumption of K2 caused transient myocardial ischemia resulting in ventricular stunning leading to acute CHF (78). Shah et al. (79) reported a case of AMI with left ventricular apical thrombus that could merely be attributed to smoking marijuana and Spice in a 24-year-old male patient. Evolution of acute ischemic strokes due to consumption of SCs has also been reported in young adults without whatsoever history of predisposing factors (85).

Thus, there is growing business concern regarding the increasing popularity of SCs because of their beingness marketed every bit "legal marijuana" among the youth, peculiarly teenagers. This highlights importance of appropriate and complete history taking when patients in this age grouping nowadays to the emergency department especially with cardiovascular events. In an effort to curb the sales and consumption of SCs, Drug Enforcement Administration (DEA) classified several of these substances as Class I schedule drugs. Of import legal considerations relevant to the utilize of SCs are the lack of sufficiently reliable tests for their detection in urine, dissimilar those available for marijuana and the classification of these drugs equally analogues of controlled substances rather than controlled substances (86). Efforts to curb its utilize via the implementation of appropriate public health strategies are imperative.

Pre- and perioperative implications of cannabis use

Cannabis users may crave surgery due to injuries or accidents occurring afterwards recent use. Cannabis has been shown to crusade significant respiratory symptoms and changes in spirometry even with relatively short elapsing of inhalation (87). Cannabis use has been associated with significant airway inflammation and alteration in histopathology in bronchial mucosa and these effects appears to be additive when cannabis is smoked in conjunction with tobacco (88). In one report, it was ended that smoking of cannabis is associated with significant airway inflammation which was like to what encountered in tobacco smokers (89). Cannabis inhalation causes increased prevalence of chronic cough/chronic bronchitis, wheezing and shortness of jiff with increased clinic visits for acute respiratory illnesses (90). Because of all these physiological and histopathological changes, patients undergoing surgery should be inquired about illicit drug use including cannabis (91,92).

The interactions between cannabis and anaesthetic agents and the effects of these interactions are poorly understood. In a prospective, randomized, single blinded report, regular cannabis users showed variable response to consecration of anaesthesia with propofol when compared to non-users, although higher doses of propofol were needed to achieve loss of consciousness, acceptable jaw relaxation and depression of airway reflexes for insertion of laryngeal mask (93). THC has likewise been reported to prolong the allaying furnishings of general amazement in experimental models (94,95), and has been implicated in perioperative complications such equally bronchospasm due to airway irritation, tachycardia, and uvular oedema (96). Cannabis leaves burn at higher temperature than similar quantity of tobacco causing increased directly airway irritation. Excessive respiratory brunt of carbon monoxide and tar tin occur with cannabis smoking when compared to smoking (91). Cannabis utilize is besides mayhap reported to be associated with diffuse alveolar haemorrhage in post-operative period in a patient which was idea to be due to (97) negative pressure pulmonary edema and possible inhibition of thrombin-driven jell formation (98).

It is important to extract history of cannabis utilise as a routine role of preoperative work up. The choice of the advisable anaesthetic agent is important in cases of cannabis users. If sedative hypnotic drugs are used in cannabis users, excessive depression of the central nervous system may occur; therefore, barbiturates, opioids, and benzodiazepines, and phenothiazines are preferably avoided. Further, contempo employ of cannabis can cause subtract blood pressure due to vasodilatation along with tachycardia leading to increased oxygen myocardial demand (99), therefore drugs which are likely to increment HR, such as ketamine, atropine, and epinephrine should likewise be avoided (100). It should also go on in mind that the intraoperative and immediate postoperative need of opiates for analgesia in patients with history of recent or chronic cannabis consumption may be significantly increased (92,101).

Thus, complete illicit drug apply history and tests to confirm cannabis apply if suspected, are necessary earlier surgical interventions It may be hard to obtain truthful and acceptable data specially because of patients' reticent but a college degree of suspicion of cannabis utilize is justified in patients with chronic hurting, h/o illicit drug utilize, or alcoholism.

Potential beneficial furnishings of cannabis in cardiovascular system

While the bulk of published data suggest a harmful issue of cannabis and cannabinoids on the cardiovascular arrangement, a few advise possible beneficial effects. The use of cannabis or marijuana has been linked to increase risk of cardiac events immediately afterward utilize, although little information is available about the long-term impact of marijuana among patients with established coronary illness. An analysis carried out on around 4,000 MI patients from a U.S. multicenter, cohort written report that were followed for up to 18 years, failed to show statistically pregnant differences in all-cause mortality (38).

Indirect beneficial effects have been demonstrated in studies showing that cannabis or marijuana employ attenuates or modulates common cardiovascular disease chance factors. Preliminary data from a small double blinded placebo controlled study carried out in the U.G. examining the furnishings of cannabidiol delivered through an inhaler on cigarette consumption amongst smokers wishing to quit smoking, suggests a forty% smoking reduction in the treatment group compared to placebo (102). Additionally, a number of epidemiologic studies have shown lower prevalence of obesity and diabetes mellitus among marijuana users compared with those who never used marijuana, suggesting a relationship between cannabinoids and metabolic processes. A study done on 4657 developed Americans from the National Wellness and Nutrition Examination Survey showed that marijuana use was associated with lower levels of fasting insulin and HOMA-IR, and smaller waist circumference (103). Furthermore, some studies hypothesized that lower rates of obesity among habitual marijuana users are directly related to the exposure to the THC present in cannabis, and proposed its potential employ for the management of obesity and its complications (104).

A recently published study on mice that tested three regimens of THC administration suggests that a pre-handling with an ultra-depression dose of THC provides a pregnant protection against an ischemic insult to the heart as evidenced by lower troponin levels, and reduced infarct size (105).

Conclusions

The fact that cannabis employ has become increasingly popular among youngsters is a major crusade for concern. It is important to consider a negative impact of cannabis abuse on education also equally the risk of abuse of other illicit drugs amid the youth on the development of psychosis. Currently, there is a lack of consensus on what position to prefer regarding legalization of cannabis. While i view regards recreational cannabis uses as harmless, the opposing viewpoint is that it raises some serious public wellness concerns and that its utilise should continue to be discouraged by governing bodies and prohibited by law (Table 2). The literature suggests the occurrence of harmful furnishings including fatal cardiovascular events that could be related to cannabis apply. Further inquiry and studies are needed to determine the impact of acute and peculiarly the chronic regular use of cannabis on diverse organ systems, peculiarly the cardiovascular arrangement.

Table 2

Tabular array ii The effects of cannabis on the cardiovascular system

Full table

With the recent decriminalization and legalisation of cannabis use in some parts of the world and the increase in the number of conditions that cannabis can be prescribed for, there is a good possibility that physicians will see more cases of cardiovascular and cerebrovascular complications of cannabis utilize in the near future. Information technology is necessary to increment awareness among physicians and the full general public alike regarding the increased hazard of cardiovascular complications associated with cannabis use. In improver, implementing effective strategies for the prudent dispersal of the drug is necessary to avoid unnecessary increases in cannabis-related complications and therefore forestall the resultant burden on public and individual health services. The electric current evidences highlight the urgent need for a change in the mindset amongst cannabis users, particularly the young regarding the agin effects of cannabis utilise and the adventure of astute coronary events, stroke, and possibly death.

Acknowledgements

Authors would like to admit Dr. Amar Shere MD for creating the online versions of all figures.

Conflicts of Involvement: The authors have no conflicts of interest to declare.

References

  1. Criminal offense UNOoDa. Globe Drug Study 2016. Bachelor online: http://www.unodc.org/wdr2016/
  2. Green KM, Johnson RM, Milam AJ, et al. Racial differences and the role of neighborhood in the sequencing of marijuana and tobacco initiation among urban youth. Subst Abus 2016;37:507-10. [Crossref] [PubMed]
  3. National Conference of State Legislatures. . Accessed October 10, 2016.www.ncsl.org/research/wellness/country-medical-marijuana-laws.aspx
  4. Hughes A, Lipari RN, Williams M. State Estimates of Adolescent Marijuana Utilise and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014. The CBHSQ Report Rockville (MD): Substance Abuse and Mental Health Services Administration (United states of america); 2013-2015 Dec 17 2015.
  5. Hoch E, Bonnetn U, Thomasius R, et al. Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int 2015;112:271-eight. [PubMed]
  6. Hall Due west, Degenhardt L. Adverse health effects of not-medical cannabis use. Lancet 2009;374:1383-91. [Crossref] [PubMed]
  7. Milroy CM, Parai JL. The histopathology of drugs of corruption. Histopathology 2011;59:579-93. [Crossref] [PubMed]
  8. Jouanjus E, Lapeyre-Mestre M, Micallef J, et al. Cannabis utilise: signal of increasing take chances of serious cardiovascular disorders. J Am Heart Assoc 2014;iii:e000638. [Crossref] [PubMed]
  9. Gaoni Y, Mechoulam R. Isolation, Structure, and Fractional Synthesis of an Active Constituent of Hashish. J Am Chem Soc 1964;86:1646-47. [Crossref]
  10. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202. [Crossref] [PubMed]
  11. Maccarrone Thou, Bab I, Bíró T, et al. Endocannabinoid signaling at the periphery: 50 years later on THC. Trends Pharmacol Sci 2015;36:277-96. [Crossref] [PubMed]
  12. Montecucco F, Di Marzo V. At the heart of the matter: the endocannabinoid system in cardiovascular office and dysfunction. Trends Pharmacol Sci 2012;33:331-forty. [Crossref] [PubMed]
  13. Hiley CR, Ford WR. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling. Biol Rev Camb Philos Soc 2004;79:187-205. [Crossref] [PubMed]
  14. Steffens S, Pacher P. Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies. Br J Pharmacol 2012;167:313-23. [Crossref] [PubMed]
  15. Franz CA, Frishman WH. Marijuana Use and Cardiovascular Illness. Cardiol Rev 2016;24:158-62. [Crossref] [PubMed]
  16. Korantzopoulos P, Liu T, Papaioannides D, et al. Atrial fibrillation and marijuana smoking. Int J Clin Pract 2008;62:308-13. [Crossref] [PubMed]
  17. Sidney S. Cardiovascular consequences of marijuana employ. J Clin Pharmacol 2002;42:64S-70S. [Crossref] [PubMed]
  18. Jones RT. Cardiovascular organisation effects of marijuana. J Clin Pharmacol 2002;42:58S-63S. [Crossref] [PubMed]
  19. Khiabani HZ, Mørland J, Bramness JG. Frequency and irregularity of heart charge per unit in drivers suspected of driving under the influence of cannabis. Eur J Intern Med 2008;nineteen:608-12. [Crossref] [PubMed]
  20. Korantzopoulos P. Marijuana smoking is associated with atrial fibrillation. Am J Cardiol 2014;113:1085-6. [Crossref] [PubMed]
  21. Sánchez Lázaro IJ, Almenar Bonet L, Sancho-Tello MJ, et al. Ventricular tachycardia due to marijuana use in a heart transplant patient. Rev Esp Cardiol 2009;62:459-61. [PubMed]
  22. Casier I, Vanduynhoven P, Haine S, et al. Is recent cannabis use associated with astute coronary syndromes? An illustrative instance series. Acta Cardiol 2014;69:131-6. [Crossref] [PubMed]
  23. Baranchuk A, Johri AM, Simpson CS, et al. Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report. Cases J 2008;1:373. [Crossref] [PubMed]
  24. Daccarett Thousand, Freih M, Machado C. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol 2007;119:235-6. [Crossref] [PubMed]
  25. Pratap B, Korniyenko A. Toxic effects of marijuana on the cardiovascular system. Cardiovasc Toxicol 2012;12:143-viii. [Crossref] [PubMed]
  26. Alonso JV, Teo BH, Pozo FJ, et al. Brugada electrocardiogram pattern induced by cannabis; is cannabis condom? Am J Emerg Med 2016;34:1738.e1-4.
  27. Ballard ME, de Wit H. Combined effects of acute, very-low-dose ethanol and delta(ix)-tetrahydrocannabinol in salubrious human volunteers. Pharmacol Biochem Behav 2011;97:627-31. [Crossref] [PubMed]
  28. Dumont GJ, Kramers C, Sweep FC, et al. Cannabis coadministration potentiates the effects of "ecstasy" on heart charge per unit and temperature in humans. Clin Pharmacol Ther 2009;86:160-6. [Crossref] [PubMed]
  29. Hodcroft CJ, Rossiter MC, Buch AN. Cannabis-associated myocardial infarction in a immature man with normal coronary arteries. J Emerg Med 2014;47:277-81. [Crossref] [PubMed]
  30. Deharo P, Massoure PL, Fourcade 50. Exercise-induced acute coronary syndrome in a 24-yr-old human being with massive cannabis consumption. Acta Cardiol 2013;68:425-eight. [Crossref] [PubMed]
  31. Ghannem M, Belhadj I, Tritar A, et al. Ann Cardiol Angeiol (Paris) 2013;62:424-8. [Cannabis and acute coronary syndrome with ST segment tiptop]. [Crossref] [PubMed]
  32. Yurtdaş Yard, Aydın MK. Acute myocardial infarction in a immature man; fatal blow of the marijuana: a case written report. Korean Circ J 2012;42:641-5. [Crossref] [PubMed]
  33. Canga Y, Osmonov D, Karataş MB, et al. Cannabis: a rare trigger of premature myocardial infarction. Anadolu Kardiyol Derg 2011;xi:272-4. [PubMed]
  34. Panayiotides IM. What is the Association of Cannabis Consumption and Cardiovascular Complications? Subst Corruption 2015;nine:1-iii. [Crossref] [PubMed]
  35. Leblanc A, Tirel-Badets A, Paleiron N, et al. Ann Cardiol Angeiol (Paris) 2011;60:154-8. [Cannabis and myocardial infarction without angiographic stenosis in young patient: guilty or not guilty? A case report]. [Crossref] [PubMed]
  36. Mittleman MA, Lewis RA, Maclure Grand, et al. Triggering myocardial infarction by marijuana. Circulation 2001;103:2805-9. [Crossref] [PubMed]
  37. Mukamal KJ, Maclure M, Muller JE, et al. An exploratory prospective report of marijuana utilise and mortality post-obit acute myocardial infarction. Am Heart J 2008;155:465-70. [Crossref] [PubMed]
  38. Frost L, Mostofsky E, Rosenbloom JI, et al. Marijuana employ and long-term mortality among survivors of astute myocardial infarction. Am Centre J 2013;165:170-5. [Crossref] [PubMed]
  39. Arora S, Goyal H, Aggarwal P, et al. ST-segment pinnacle myocardial infarction in a 37-year-old man with normal coronaries--it is non always cocaine! Am J Emerg Med 2012;30:2091.e3-5. [Crossref]
  40. McLeod AL, McKenna CJ, Northridge DB. Myocardial infarction post-obit the combined recreational use of Viagra and cannabis. Clin Cardiol 2002;25:133-4. [Crossref] [PubMed]
  41. Aronow WS, Cassidy J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med 1974;291:65-7. [Crossref] [PubMed]
  42. Deusch E, Kress HG, Kraft B, et al. The procoagulatory furnishings of delta-9-tetrahydrocannabinol in human platelets. Anesth Analg 2004;99:1127-30. table of contents. [Crossref] [PubMed]
  43. Karch SB. Cannabis and cardiotoxicity. Forensic Sci Med Pathol 2006;two:13-8. [Crossref] [PubMed]
  44. O'Sullivan SE, Tarling EJ, Bennett AJ, et al. Novel time-dependent vascular deportment of Delta9-tetrahydrocannabinol mediated past peroxisome proliferator-activated receptor gamma. Biochem Biophys Res Commun 2005;337:824-31. [Crossref] [PubMed]
  45. O'Sullivan SE, Kendall DA, Randall Doctor. Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 2006;317:428-38. [Crossref] [PubMed]
  46. O'Sullivan SE, Sun Y, Bennett AJ, et al. Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol 2009;612:61-8. [Crossref] [PubMed]
  47. Vandrey R, Umbricht A, Strain EC. Increased blood pressure after abrupt cessation of daily cannabis use. J Addict Med 2011;five:16-xx. [Crossref] [PubMed]
  48. Bonnet U. Precipitous Quitting of Long-term Heavy Recreational Cannabis Utilize is Non Followed by Pregnant Changes in Blood Pressure level and Heart Charge per unit. Pharmacopsychiatry 2016;49:23-v. [Crossref] [PubMed]
  49. Alshaarawy O, Elbaz HA. Cannabis use and blood force per unit area levels: Us National Health and Nutrition Test Survey, 2005-2012. J Hypertens 2016;34:1507-12. [Crossref] [PubMed]
  50. Malinowska B, Baranowska-Kuczko M, Schlicker E. Triphasic blood pressure level responses to cannabinoids: do we understand the mechanism? Br J Pharmacol 2012;165:2073-88. [Crossref] [PubMed]
  51. Grotenhermen F. Cannabis-associated arteritis. Vasa 2010;39:43-53. [Crossref] [PubMed]
  52. Karila L, Roux P, Rolland B, et al. Acute and long-term effects of cannabis use: a review. Curr Pharm Des 2014;20:4112-eight. [Crossref] [PubMed]
  53. Cottencin O, Karila L, Lambert K, et al. Cannabis arteritis: review of the literature. J Addict Med 2010;4:191-vi. [Crossref] [PubMed]
  54. Peyrot I, Garsaud AM, Saint-Cyr I, et al. Cannabis arteritis: a new case report and a review of literature. J Eur Acad Dermatol Venereol 2007;21:388-91. [Crossref] [PubMed]
  55. Lou JY, Randhawa MS, Hornacek D, et al. Images in vascular medicine. Spontaneous renal artery dissection in a cannabis user. Vasc Med 2015;20:379-80. [Crossref] [PubMed]
  56. Corvi F, Querques Grand, Lattanzio R, et al. Key retinal vein occlusion in a young patient following cannabis smoke inhalation. Eur J Ophthalmol 2014;24:437-twoscore. [Crossref] [PubMed]
  57. Bucci F, Redler A, Fiengo L. Critical limb ischemia in a immature homo: saddle embolism or unusual presentation of thromboangiitis obliterans? Case Rep Vasc Med 2013;2013:830540. [Crossref] [PubMed]
  58. Ulenaers M, Buchel OC, Van Olmen A, et al. An uncommon cause of visceral arterial embolism in patients presenting with astute abdominal pain: a report of 2 cases. Acta Gastroenterol Belg 2010;73:55-60. [PubMed]
  59. Thanvi BR, Treadwell SD. Cannabis and stroke: is at that place a link? Postgrad Med J 2009;85:lxxx-three. [Crossref] [PubMed]
  60. Rumalla M, Reddy AY, Mittal MK. Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States. J Neurol Sci 2016;364:191-6. [Crossref] [PubMed]
  61. Wolff Five, Lauer Five, Rouyer O, et al. Cannabis utilize, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective report in 48 sequent immature patients. Stroke 2011;42:1778-80. [Crossref] [PubMed]
  62. Tsivgoulis Grand, Lachanis Southward, Papathanasiou MA, et al. Cannabis-associated angiopathy: an uncommon crusade of crescendo transient ischemic attacks. Circulation 2014;130:2069-seventy. [Crossref] [PubMed]
  63. Hackam DG. Cannabis and stroke: systematic appraisal of case reports. Stroke 2015;46:852-vi. [Crossref] [PubMed]
  64. Desbois Air-conditioning, Cacoub P. Cannabis-associated arterial illness. Ann Vasc Surg 2013;27:996-1005. [Crossref] [PubMed]
  65. Ntlholang O, McDonagh R, Nicholson South, et al. Is intimal hyperplasia associated with cranial arterial stenosis in cannabis-associated cognitive infarction? Int J Stroke 2015;10:E56-ix. [Crossref] [PubMed]
  66. Wolff V, Schlagowski AI, Rouyer O, et al. Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke. Biomed Res Int 2015;2015:323706. [Crossref] [PubMed]
  67. Ince B, Benbir Yard, Yuksel O, et al. Both hemorrhagic and ischemic stroke following loftier doses of cannabis consumption. Presse Med 2015;44:106-7. [Crossref] [PubMed]
  68. Rumalla Grand, Reddy AY, Mittal MK. Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis 2016;25:452-threescore. [Crossref] [PubMed]
  69. Behrouz R, Birnbaum L, Grandhi R, et al. Cannabis Utilise and Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke 2016;47:1371-three. [Crossref] [PubMed]
  70. Di Napoli Thousand, Zha AM, Godoy DA, et al. Prior Cannabis Use Is Associated with Effect after Intracerebral Hemorrhage. Cerebrovasc Dis 2016;41:248-55. [Crossref] [PubMed]
  71. Wolff V, Armspach JP, Lauer V, et al. Cannabis-related stroke: myth or reality? Stroke 2013;44:558-63. [Crossref] [PubMed]
  72. Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective serial of 67 patients. Brain 2007;130:3091-101. [Crossref] [PubMed]
  73. Wolff V, Armspach JP, Lauer V, et al. Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: a variant of the reversible cerebral vasoconstriction syndrome? Cerebrovasc Dis 2015;39:31-8. [Crossref] [PubMed]
  74. Wolff V, Ducros A. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache. Headache 2016;56:674-87. [Crossref] [PubMed]
  75. Ting JY. Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult. Clin Toxicol (Phila) 2007;45:432-4. [Crossref] [PubMed]
  76. Kaushik M, Alla VM, Madan R, et al. Recurrent stress cardiomyopathy with variable regional involvement: insights into etiopathogenetic mechanisms. Circulation 2011;124:e556-7. [Crossref] [PubMed]
  77. Rodríguez-Castro CE, Alkhateeb H, Elfar A, et al. Recurrent myopericarditis as a complication of Marijuana use. Am J Instance Rep 2014;15:lx-2. [Crossref] [PubMed]
  78. Orsini J, Blaak C, Tam Eastward, et al. The Wide and Unpredictable Telescopic of Synthetic Cannabinoids Toxicity. Example Rep Crit Intendance 2015;2015:542490. [Crossref] [PubMed]
  79. Shah M, Garg J, Patel B, et al. Can your center handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus. Int J Cardiol 2016;215:129-31. [Crossref] [PubMed]
  80. Castaneto MS, Gorelick DA, Desrosiers NA, et al. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014;144:12-41. [Crossref] [PubMed]
  81. Bush DM, Woodwell DA. Update: Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids. The CBHSQ Report Rockville (Md): Substance Abuse and Mental Health Services Administration (US); 2013-2014 Oct 16 2013-2014.
  82. Cooper ZD. Adverse Furnishings of Constructed Cannabinoids: Direction of Acute Toxicity and Withdrawal. Curr Psychiatry Rep 2016;eighteen:52. [Crossref] [PubMed]
  83. Tait RJ, Caldicott D, Mount D, et al. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 2016;54:i-13. [Crossref] [PubMed]
  84. Obafemi AI, Kleinschmidt K, Goto C, et al. Cluster of Acute Toxicity from Ingestion of Constructed Cannabinoid-Laced Brownies. J Med Toxicol 2015;11:426-9. [Crossref] [PubMed]
  85. Tournebize J, Gibaja Five, Kahn JP. Acute effects of synthetic cannabinoids: Update 2015. Subst Abus 2016.1-23. [Crossref] [PubMed]
  86. Wells DL, Ott CA. The "new" marijuana. Ann Pharmacother 2011;45:414-7. [Crossref] [PubMed]
  87. Taylor DR, Poulton R, Moffitt TE, et al. The respiratory effects of cannabis dependence in young adults. Addiction 2000;95:1669-77. [Crossref] [PubMed]
  88. Fligiel SE, Roth MD, Kleerup EC, et al. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 1997;112:319-26. [Crossref] [PubMed]
  89. Roth MD, Arora A, Barsky SH, et al. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 1998;157:928-37. [Crossref] [PubMed]
  90. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc 2013;10:239-47. [Crossref] [PubMed]
  91. Wong GT, Irwin MG. Poisoning with illicit substances: toxicology for the anaesthetist. Anaesthesia 2013;68 Suppl 1:117-24. [Crossref] [PubMed]
  92. Karam M, Abbasi S, Khan FA. Anaesthetic consideration in a cannabis addict. J Coll Physicians Surg Pak 2015;25 Suppl 1:S2-3. [PubMed]
  93. Flisberg P, Paech MJ, Shah T, et al. Induction dose of propofol in patients using cannabis. Eur J Anaesthesiol 2009;26:192-v. [Crossref] [PubMed]
  94. Chesher GB, Jackson DM, Starmer GA. Interaction of cannabis and full general anaesthetic agents in mice. Br J Pharmacol 1974;50:593-9. [Crossref] [PubMed]
  95. Frizza J, Chesher GB, Jackson DM, et al. The effect of delta 9-tetrahydrocannabinol, cannabidiol, and cannabinol on the amazement induced by various anaesthetic agents in mice. Psychopharmacology (Berl) 1977;55:103-vii. [Crossref] [PubMed]
  96. Mallat A, Roberson J, Brock-Utne JG. Preoperative marijuana inhalation--an airway concern. Can J Anaesth 1996;43:691-three. [Crossref] [PubMed]
  97. Kim CA, Liu R, Hsia DW. Lengthened alveolar hemorrhage induced by sevoflurane. Ann Am Thorac Soc 2014;11:853-5. [Crossref] [PubMed]
  98. Murray AW, Smith JD, Ibinson JW. Diffuse alveolar hemorrhage, anesthesia, and cannabis. Ann Am Thorac Soc 2014;11:1338-nine. [Crossref] [PubMed]
  99. Bryson EO, Frost EA. The perioperative implications of tobacco, marijuana, and other inhaled toxins. Int Anesthesiol Clin 2011;49:103-18. [Crossref] [PubMed]
  100. Hernandez M, Birnbach DJ, Van Zundert AA. Coldhearted management of the illicit-substance-using patient. Curr Opin Anaesthesiol 2005;18:315-24. [Crossref] [PubMed]
  101. Jefferson DA, Harding HE, Cawich SO, et al. Postoperative analgesia in the Jamaican cannabis user. J Psychoactive Drugs 2013;45:227-32. [Crossref] [PubMed]
  102. Morgan CJ, Das RK, Joye A, et al. Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addict Behav 2013;38:2433-6. [Crossref] [PubMed]
  103. Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med 2013;126:583-9. [Crossref] [PubMed]
  104. Le Foll B, Trigo JM, Sharkey KA, et al. Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss? Med Hypotheses 2013;lxxx:564-vii. [Crossref] [PubMed]
  105. Waldman M, Hochhauser E, Fishbein M, et al. An ultra-low dose of tetrahydrocannabinol provides cardioprotection. Biochem Pharmacol 2013;85:1626-33. [Crossref] [PubMed]

Cite this article as: Goyal H, Awad HH, Ghali JK. Part of cannabis in cardiovascular disorders. J Thorac Dis 2017;9(seven):2079-2092. doi: 10.21037/jtd.2017.06.104

douglaswhinevesock.blogspot.com

Source: https://jtd.amegroups.com/article/view/14437/html

0 Response to "Cardiovascular Risk Associated With Medical Use of Opioids and Cannabinoids a Systematic Review"

Post a Comment

Subscribe to: Post Comments (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel